Journal of Cancer Research and Therapeutics Close
 

Figure 3: Adenocarcinoma NOS, well-differentiated (a, H and E), positive p21 expression (b), and high Ki67 expression (c) (×40)

Figure 3: Adenocarcinoma NOS, well-differentiated (a, H and E), positive p21 expression (b), and high Ki67 expression (c) (×40)